Anthem Biosciences consolidated net profit rises 21.93% in the September 2026 quarter
(04 Nov 2026)
Back
Net profit of Anthem Biosciences rose 21.93% to Rs 211.46 crore in the quarter ended September 2026 as against Rs 173.43 crore during the previous quarter ended September 2025. Sales rose 8.00% to Rs 594.03 crore in the quarter ended September 2026 as against Rs 550.03 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | | Sep. 2026 | Sep. 2025 | % Var. |
| Sales | 594.03 | 550.03 | 8 |
| OPM % | 45.70 | 39.62 | - |
| PBDT | 327.08 | 263.10 | 24 |
| PBT | 296.37 | 229.60 | 29 |
| NP | 211.46 | 173.43 | 22 |
|